Who is sponsoring NCT05957211?

NCT05957211 is sponsored by University of Waterloo.

What condition does NCT05957211 study?

NCT05957211 studies Dry Eye Disease.

What drugs are being tested in NCT05957211?

Interventions: 0.09% cyclosporine A ophthalmic solution.

What is the status of NCT05957211?

NCT05957211 is currently COMPLETED.

Last reviewed 2024-08-09 · How we verify

Improving Drop Instillation Comfort of a Cyclosporine A Solution

NCT05957211 NA COMPLETED

Patients who suffer from dry eye disease are often prescribed eye drops containing cyclosporine A that help with reducing inflammation. The newest eye drop containing cyclosporine A is called Cequa (Sun Pharma, Canada). Unfortunately, nearly a quarter of (24.2%) of patients using Cequa have reported some form of discomfort (burning and stinging) when instilling the drops. This potentially discourages patients from continuing the eye drop, which prevents their dry eye disease from being managed effectively. This study is trying to determine if refrigerating the eye drops would allow the drops to feel more comfortable when they are instilled in the eye.

Details

Lead sponsor	University of Waterloo
Phase	NA
Status	COMPLETED
Enrolment	40
Start date	Fri May 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Dry Eye Disease

Interventions

0.09% cyclosporine A ophthalmic solution

Countries

Canada